Michael E. Kamarck

2.1k citations
33 papers · 1.8k · 1 hit paper · h-index 18

Impact in

Papers in

    • CRISPR and Genetic Engineering 6
    • RNA Interference and Gene Delivery 5
    • Viral Infectious Diseases and Gene Expression in Insects 4
    • Glycosylation and Glycoproteins Research 2
    • Monoclonal and Polyclonal Antibodies Research 11

Michael E. Kamarck

30 papers receiving 1.7k citations

Michael E. Kamarck's Hit Papers

The major human rhinovirus receptor is ICAM-1 1989 · 977 citations
9770+12+24Years since publication250500750

Peers

Michael E. Kamarck
Comparison fields: 5 of 103
  • Immunology and Allergy 261
  • Immunology 505
  • Radiology, Nuclear Medicine and Imaging 424
  • Cardiology and Cardiovascular Medicine 284
  • Epidemiology 402
Replace Carla Forte with:
Carla Forte United States
Christopher W. Marlor United States
C H Heusser Switzerland
F W Fitch United States
Marlyn P. Langford United States
K H Grabstein United States
Şefik Ş. Alkan United States
Shlomo Z. Ben‐Sasson United States
J H Schumacher United States
Robert M. Woods United States
Michael E. Kamarck relative to Carla Forte United States Carla Forte's profile →
Citations per field
00.5×1.5×
Carla Forte · 1×
Citations per year

Countries citing papers authored by Michael E. Kamarck

Since Specialization
Citations

This map shows the geographic impact of Michael E. Kamarck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Kamarck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Kamarck more than expected).

Fields of papers citing papers by Michael E. Kamarck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Kamarck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Kamarck. The network helps show where Michael E. Kamarck may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael E. Kamarck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael E. Kamarck Line = papers co-authored together Michael E. Kamarck links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The major human rhinovirus receptor is ICAM-1
Hit paper breakdown →
1989977
2 1989163
3 198288
4 199460
5
cDNA cloning and mapping of the human creatine kinase M gene to 19q13.
198755
6 198239
7 200637
8 199037
9 198733
10 198631
11
The isolation and characterization of polycyclic hydrocarbon-binding proteins from mouse liver and skin cytosols.
197531
12 197730
13 198430
14 198230
15 198123
16 198421
17 198421
18 202120
19
An approach to the cloning of cell surface protein genes. Selection by cell sorting of mouse L-cells that express HLA or 4F2 antigens after transformation with total human DNA.
198315
20 199114

About Michael E. Kamarck

Michael E. Kamarck is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Genetics, Immunology and Oncology, having authored 33 papers that have together received 1.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (11 papers), Virus-based gene therapy research (8 papers), CRISPR and Genetic Engineering (6 papers), RNA Interference and Gene Delivery (5 papers), CAR-T cell therapy research (4 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers), Alzheimer's disease research and treatments (2 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Immunology and Allergy (261 citations), Immunology (505 citations), Radiology, Nuclear Medicine and Imaging (424 citations), Cardiology and Cardiovascular Medicine (284 citations) and Epidemiology (402 citations). Michael E. Kamarck has collaborated with scholars based in United States and Canada. Frequent co-authors include Gary L. Davis, Alan McClelland, Jeffrey M. Greve, Christopher W. Marlor, Carla Forte, Susan Yost, J A Barbosa, John Hart, Frank H. Ruddle and James J. Elting. Their work appears in journals such as The Journal of Immunology, Journal of Immunological Methods, Experimental Cell Research, Proceedings of the National Academy of Sciences and Methods in enzymology on CD-ROM/Methods in enzymology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact